Skip to main content

Advertisement

SpringerLink
Log in

Long-term clinical and urodynamic effectiveness of augmentation ileocystoplasty with supra-trigonal cystectomy in individuals with spinal cord injury

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

This study aimed to determine the long-term effectiveness of augmentation ileocystoplasty (AI) associated with supra-trigonal cystectomy on clinical and urodynamic variables, and the safety of the intervention in individuals with spinal cord injury (SCI).

Materials and methods

Single-center, retrospective study of all patients with SCI who underwent AI with supra-trigonal cystectomy from January 1994, with a follow-up of more than 8 years. The primary outcome was the sustained long-term effectiveness of AI with supra-trigonal cystectomy on clinical and urodynamic variables. The secondary outcome was the long-term safety of this procedure.

Results

We included 77 patients: 57% were female, mean (SD) age was 52.0 (13.0) years, 77% had paraplegia, and median time since onset was 25.0 [19; 30] years. Long-term success rate (evaluated 13 [10; 15] years post AI) was 93.5% for urodynamic parameters and 76.6% for urinary incontinence. Results of the short- and long-term post-AI assessments did not differ for any urodynamic or clinical variables. Bladder lithiasis occurred in 20.5% of cases and ≥ 1 febrile urinary tract infection occurred in 55.8%, mostly within the first 2 years of follow-up. No cases of bladder cancer were diagnosed.

Conclusion

AI associated with supra-trigonal cystectomy in patients with SCI is safe and effective in both the short term and long term. Regular urodynamic assessment is not necessary in clinically stable patients with low bladder risk; however, close monitoring is important because of the risk of urological complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Haab F (2014) Chapter 1: the conditions of neurogenic detrusor overactivity and overactive bladder. Neurourol Urodyn 33(Suppl 3):S2–S5. https://doi.org/10.1002/nau.22636

    Article  PubMed  Google Scholar 

  2. Gajewski JB, Schurch B, Hamid R et al (2018) An international continence society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD). Neurourol Urodyn 37:1152–1161. https://doi.org/10.1002/nau.23397

    Article  PubMed  Google Scholar 

  3. Myers JB, Lenherr SM, Stoffel JT et al (2019) Patient reported bladder related symptoms and quality of life after spinal cord injury with different bladder management strategies. J Urol 202:574–584. https://doi.org/10.1097/JU.0000000000000270

    Article  PubMed  Google Scholar 

  4. Gormley EA (2010) Urologic complications of the neurogenic bladder. Urol Clin North Am 37:601–607. https://doi.org/10.1016/j.ucl.2010.07.002

    Article  PubMed  Google Scholar 

  5. Nambiar A, Lucas M (2014) Chapter 4: guidelines for the diagnosis and treatment of overactive bladder (OAB) and neurogenic detrusor overactivity (NDO). Neurourol Urodyn 33(Suppl 3):S21-25. https://doi.org/10.1002/nau.22631

    Article  PubMed  Google Scholar 

  6. Wyndaele J-J, Birch B, Borau A et al (2018) Surgical management of the neurogenic bladder after spinal cord injury. World J Urol 36:1569–1576. https://doi.org/10.1007/s00345-018-2294-7

    Article  PubMed  Google Scholar 

  7. Chen J-L, Kuo H-C (2009) Long-term outcomes of augmentation enterocystoplasty with an ileal segment in patients with spinal cord injury. J Formos Med Assoc 108:475–480. https://doi.org/10.1016/S0929-6646(09)60095-4

    Article  PubMed  Google Scholar 

  8. Chartier-Kastler EJ, Mongiat-Artus P, Bitker MO et al (2000) Long-term results of augmentation cystoplasty in spinal cord injury patients. Spinal Cord 38:490–494. https://doi.org/10.1038/sj.sc.3101033

    Article  CAS  PubMed  Google Scholar 

  9. Khastgir J, Hamid R, Arya M et al (2003) Surgical and patient reported outcomes of “clam” augmentation ileocystoplasty in spinal cord injured patients. Eur Urol 43:263–269. https://doi.org/10.1016/s0302-2838(03)00008-3

    Article  CAS  PubMed  Google Scholar 

  10. Nomura S, Ishido T, Tanaka K, Komiya A (2002) Augmentation ileocystoplasty in patients with neurogenic bladder due to spinal cord injury or spina bifida. Spinal Cord 40:30–33. https://doi.org/10.1038/sj.sc.3101249

    Article  CAS  PubMed  Google Scholar 

  11. Gurung PMS, Attar KH, Abdul-Rahman A et al (2012) Long-term outcomes of augmentation ileocystoplasty in patients with spinal cord injury: a minimum of 10 years of follow-up. BJU Int 109:1236–1242. https://doi.org/10.1111/j.1464-410X.2011.10509.x

    Article  PubMed  Google Scholar 

  12. Perrouin-Verbe M-A, Léon P, Denys P et al (2019) Long-term functional outcomes of augmentation cystoplasty in adult spina bifida patients: a single-center experience in a multidisciplinary team. Neurourol Urodyn 38:330–337. https://doi.org/10.1002/nau.23857

    Article  PubMed  Google Scholar 

  13. Wu S-Y, Jiang Y-H, Kuo H-C (2017) Long-term outcomes of augmentation enterocystoplasty in patients with end-stage bladder diseases: a single-institute experience involving 102 patients. Int Neurourol J 21:133–138. https://doi.org/10.5213/inj.1732708.354

    Article  PubMed  PubMed Central  Google Scholar 

  14. Baron M, Peyronnet B, Aublé A et al (2019) Long-term discontinuation of botulinum toxin a intradetrusor injections for neurogenic detrusor overactivity: a multicenter study. J Urol 201:769–776. https://doi.org/10.1016/j.juro.2018.10.012

    Article  PubMed  Google Scholar 

  15. Joussain C, Popoff M, Phé V et al (2018) Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxinA injections for the treatment of refractory neurogenic detrusor overactivity. Neurourol Urodyn 37:799–806. https://doi.org/10.1002/nau.23352

    Article  CAS  PubMed  Google Scholar 

  16. Frontera JE, Mollett P (2017) Aging with spinal cord injury: an update. Phys Med Rehabil Clin N Am 28:821–828. https://doi.org/10.1016/j.pmr.2017.06.013

    Article  PubMed  Google Scholar 

  17. Schurch B, Iacovelli V, Averbeck MA et al (2018) Urodynamics in patients with spinal cord injury: a clinical review and best practice paper by a working group of the international continence society urodynamics committee. Neurourol Urodyn 37:581–591. https://doi.org/10.1002/nau.23369

    Article  PubMed  Google Scholar 

  18. Peyronnet B, Sanson S, Amarenco G et al (2015) Definition of botulinum toxin failure in neurogenic detrusor overactivity: preliminary results of the DETOX survey. Prog Urol 25:1219–1224. https://doi.org/10.1016/j.purol.2015.07.006

    Article  CAS  PubMed  Google Scholar 

  19. Michel F, Ciceron C, Bernuz B et al (2019) Botulinum toxin type A injection after failure of augmentation enterocystoplasty performed for neurogenic detrusor overactivity: preliminary results of a salvage strategy. The ENTEROTOX Study Urology 129:43–47. https://doi.org/10.1016/j.urology.2019.03.010

    Article  PubMed  Google Scholar 

  20. Apostolidis A, Drake MJ, Emmanuel A, et al. (2017) Neurologic urinary and faecal incontinence In: Abrams P, Cardozo L; Wagg A, Wein A (eds) Incontinence, 6th edition. Health Publication, © ICUD ICS 2016, pp 1093–1308

  21. Kokorowski PJ, Routh JC, Borer JG et al (2011) Screening for malignancy after augmentation cystoplasty in children with spina bifida: a decision analysis. J Urol 186:1437–1443. https://doi.org/10.1016/j.juro.2011.05.065

    Article  PubMed  Google Scholar 

  22. Hoen L’t, Ecclestone H, Blok BFM et al (2017) Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder. Neurourol Urodyn. 36(1685):1702. https://doi.org/10.1002/nau.23205

    Article  Google Scholar 

  23. Anquetil C, Abdelhamid S, Gelis A, Fattal C (2016) Botulinum toxin therapy for neurogenic detrusor hyperactivity versus augmentation enterocystoplasty: impact on the quality of life of patients with SCI. Spinal Cord 54:1031–1035. https://doi.org/10.1038/sc.2016.49

    Article  CAS  PubMed  Google Scholar 

  24. Somani BK, Kumar V, Wong S et al (2007) Bowel dysfunction after transposition of intestinal segments into the urinary tract: 8 year prospective cohort study. J Urol 177:1793–1798. https://doi.org/10.1016/j.juro.2007.01.038

    Article  PubMed  Google Scholar 

  25. Pavlović K, Hrkać A, Kožul IS et al (2021) Long-term results of augmentation ileocystoplasty in spinal cord injury patients. Cent European J Urol 74:178–184. https://doi.org/10.5173/ceju.2021.0333.R1

    Article  PubMed  PubMed Central  Google Scholar 

  26. Hensle TW, Reiley EA, Fam MM, Carpenter CP (2016) Enterocystoplasty: the long-term effects on bone mineral density. J Pediatr Urol 12:245.e1–6. https://doi.org/10.1016/j.jpurol.2016.02.017

    Article  Google Scholar 

  27. Gilbert SM, Hensle TW (2005) Metabolic consequences and long-term complications of enterocystoplasty in children: a review. J Urol 173:1080–1086. https://doi.org/10.1097/01.ju.0000155248.57049.4e

    Article  PubMed  Google Scholar 

  28. Sahai A, Cortes E, Seth J et al (2011) Neurogenic detrusor overactivity in patients with spinal cord injury: evaluation and management. Curr Urol Rep 12:404–412. https://doi.org/10.1007/s11934-011-0221-1

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuro-Uro-Andrology Hospital Universitaire R.Poincare, AP-HP, 104 bvd R. Poincare, 92380, Garches, France

    A. Balanca, A. Even, E. Chartier-Kastler, P. Denys & C. Joussain

  2. Department of Urology, APHP-Pitié-Salpétrière Hospital, Sorbonne Université, Paris, France

    E. Chartier-Kastler

  3. Inserm U1179, UFR Des Sciences de la Santé, University of Versailles Saint-Quentin, Montigny-le-Bretonneux, France

    E. Chartier-Kastler, P. Denys & C. Joussain

  4. Department of Sport Medicine and Readaptation, Hôpital Foch, 92150, Suresnes, France

    C. Malot

Authors
  1. A. Balanca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Even
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Malot
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Chartier-Kastler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Denys
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Joussain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Joussain.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 20 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Balanca, A., Even, A., Malot, C. et al. Long-term clinical and urodynamic effectiveness of augmentation ileocystoplasty with supra-trigonal cystectomy in individuals with spinal cord injury. World J Urol 40, 2121–2127 (2022). https://doi.org/10.1007/s00345-022-04028-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-022-04028-w

Keywords

Search

Navigation